| A randomized clinical trial of intravitreal bevacizumab versus intravitreal dexamethasone for diabetic macular edema: the BEVORDEX study MC Gillies, LL Lim, A Campain, GJ Quin, W Salem, J Li, S Goodwin, ... Ophthalmology 121 (12), 2473-2481, 2014 | 368 | 2014 |
| Gene expression profiling reveals renin mRNA overexpression in human hypertensive kidneys and a role for microRNAs FZ Marques, AE Campain, M Tomaszewski, E Zukowska-Szczechowska, ... Hypertension 58 (6), 1093-1098, 2011 | 275 | 2011 |
| Long-term outcomes of treatment of neovascular age-related macular degeneration: data from an observational study MC Gillies, A Campain, D Barthelmes, JM Simpson, JJ Arnold, ... Ophthalmology 122 (9), 1837-1845, 2015 | 273 | 2015 |
| BRAF mutation, NRAS mutation, and the absence of an immune-related expressed gene profile predict poor outcome in patients with stage III melanoma GJ Mann, GM Pupo, AE Campain, CD Carter, SJ Schramm, S Pianova, ... Journal of Investigative Dermatology 133 (2), 509-517, 2013 | 204 | 2013 |
| Two-year outcomes of “treat and extend” intravitreal therapy for neovascular age-related macular degeneration JJ Arnold, A Campain, D Barthelmes, JM Simpson, RH Guymer, ... Ophthalmology 122 (6), 1212-1219, 2015 | 203 | 2015 |
| Comparison study of microarray meta-analysis methods A Campain, YH Yang BMC bioinformatics 11, 1-11, 2010 | 120 | 2010 |
| Two year outcomes of “treat and extend” intravitreal therapy using aflibercept preferentially for neovascular age-related macular degeneration D Barthelmes, V Nguyen, V Daien, A Campain, R Walton, R Guymer, ... Retina 38 (1), 20-28, 2018 | 107 | 2018 |
| Bevacizumab or dexamethasone implants for DME: 2-year results (the BEVORDEX study) S Fraser-Bell, LL Lim, A Campain, H Mehta, C Aroney, J Bryant, J Li, ... Ophthalmology 123 (6), 1399-1401, 2016 | 94 | 2016 |
| Anti‐vascular endothelial growth factor combined with intravitreal steroids for diabetic macular oedema H Mehta, C Hennings, MC Gillies, V Nguyen, A Campain, S Fraser‐Bell Cochrane Database of Systematic Reviews, 2018 | 73 | 2018 |
| Meta-analysis of genome-wide gene expression differences in onset and maintenance phases of genetic hypertension FZ Marques, AE Campain, YHJ Yang, BJ Morris Hypertension 56 (2), 319-324, 2010 | 71 | 2010 |
| Review and cross-validation of gene expression signatures and melanoma prognosis SJ Schramm, AE Campain, RA Scolyer, YH Yang, GJ Mann Journal of Investigative Dermatology 132 (2), 274-283, 2012 | 70 | 2012 |
| Effects of switching from ranibizumab to aflibercept in eyes with exudative age-related macular degeneration D Barthelmes, A Campain, P Nguyen, JJ Arnold, IL McAllister, ... British Journal of Ophthalmology 100 (12), 1640-1645, 2016 | 45 | 2016 |
| Efficacy of dexamethasone versus bevacizumab on regression of hard exudates in diabetic maculopathy: data from the BEVORDEX randomised clinical trial H Mehta, S Fraser-Bell, A Yeung, A Campain, LL Lim, GJ Quin, ... British Journal of Ophthalmology 100 (7), 1000-1004, 2016 | 42 | 2016 |
| Global identification of the genes and pathways differentially expressed in hypothalamus in early and established neurogenic hypertension FZ Marques, AE Campain, PJ Davern, YHJ Yang, GA Head, BJ Morris Physiological genomics 43 (12), 766-771, 2011 | 39 | 2011 |
| Genes influencing circadian differences in blood pressure in hypertensive mice FZ Marques, AE Campain, PJ Davern, YHJ Yang, GA Head, BJ Morris PloS one 6 (4), e19203, 2011 | 36 | 2011 |
| Time to initial clinician-reported inactivation of neovascular age-related macular degeneration treated primarily with ranibizumab MC Gillies, A Campain, R Walton, JM Simpson, JJ Arnold, RH Guymer, ... Ophthalmology 122 (3), 589-594. e1, 2015 | 29 | 2015 |
| A prediction model for viability at the end of the first trimester after a single early pregnancy evaluation J Oates, I Casikar, A Campain, S Müller, J Yang, S Reid, G Condous Australian and New Zealand Journal of Obstetrics and Gynaecology 53 (1), 51-57, 2013 | 26 | 2013 |
| Outcomes of persistently active neovascular age-related macular degeneration treated with VEGF inhibitors: observational study data D Barthelmes, R Walton, AE Campain, JM Simpson, JJ Arnold, ... British Journal of Ophthalmology 99 (3), 359-364, 2015 | 25 | 2015 |
| Prevalence, incidence and risk factors of diabetes in Australian adults aged≥ 45 years: A cohort study using linked routinely-collected data H Zhang, K Rogers, L Sukkar, M Jun, A Kang, T Young, A Campain, ... Journal of clinical & translational endocrinology 22, 100240, 2020 | 22 | 2020 |
| Implementing cardiovascular disease preventive care guidelines in general practice: an opportunity missed CM Hespe, A Campain, R Webster, A Patel, L Rychetnik, MF Harris, ... Med J Aust 213 (7), 327-8, 2020 | 21 | 2020 |
